These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 15913852

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Frequency and phenotype of EHV-1 specific, IFN-gamma synthesising lymphocytes in ponies: the effects of age, pregnancy and infection.
    Paillot R, Daly JM, Luce R, Montesso F, Davis-Poynter N, Hannant D, Kydd JH.
    Dev Comp Immunol; 2007; 31(2):202-14. PubMed ID: 16824599
    [Abstract] [Full Text] [Related]

  • 4. Characterisation of CTL and IFN-gamma synthesis in ponies following vaccination with a NYVAC-based construct coding for EHV-1 immediate early gene, followed by challenge infection.
    Paillot R, Ellis SA, Daly JM, Audonnet JC, Minke JM, Davis-Poynter N, Hannant D, Kydd JH.
    Vaccine; 2006 Mar 06; 24(10):1490-500. PubMed ID: 16269205
    [Abstract] [Full Text] [Related]

  • 5. Cytokine responses to EHV-1 infection in immune and non-immune ponies.
    Coombs DK, Patton T, Kohler AK, Soboll G, Breathnach C, Townsend HG, Lunn DP.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):109-16. PubMed ID: 16473413
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies.
    Soboll G, Hussey SB, Whalley JM, Allen GP, Koen MT, Santucci N, Fraser DG, Macklin MD, Swain WF, Lunn DP.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):81-95. PubMed ID: 16549215
    [Abstract] [Full Text] [Related]

  • 8. Equine herpesvirus-1-specific interferon gamma (IFNgamma) synthesis by peripheral blood mononuclear cells in thoroughbred horses.
    Luce R, Shepherd M, Paillot R, Blacklawst B, Wood JL, Kydd JH.
    Equine Vet J; 2007 May 15; 39(3):202-9. PubMed ID: 17520969
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Detection of equine herpesvirus-specific effector and memory cytotoxic immunity in the equine upper respiratory tract.
    Breathnach CC, Yeargan MR, Timoney JF, Allen GP.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):117-25. PubMed ID: 16472871
    [Abstract] [Full Text] [Related]

  • 11. Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus.
    Holmes MA, Townsend HG, Kohler AK, Hussey S, Breathnach C, Barnett C, Holland R, Lunn DP.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):67-80. PubMed ID: 16476488
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The equine immune response to equine herpesvirus-1: the virus and its vaccines.
    Kydd JH, Townsend HG, Hannant D.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):15-30. PubMed ID: 16476492
    [Abstract] [Full Text] [Related]

  • 16. A vectored equine herpesvirus type 1 (EHV-1) vaccine elicits protective immune responses against EHV-1 and H3N8 equine influenza virus.
    Van de Walle GR, May MA, Peters ST, Metzger SM, Rosas CT, Osterrieder N.
    Vaccine; 2010 Jan 22; 28(4):1048-55. PubMed ID: 19897066
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
    Minke JM, Fischer L, Baudu P, Guigal PM, Sindle T, Mumford JA, Audonnet JC.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):47-57. PubMed ID: 16580075
    [Abstract] [Full Text] [Related]

  • 19. Deletion of the ORF2 gene of the neuropathogenic equine herpesvirus type 1 strain Ab4 reduces virulence while maintaining strong immunogenicity.
    Schnabel CL, Wimer CL, Perkins G, Babasyan S, Freer H, Watts C, Rollins A, Osterrieder N, Wagner B.
    BMC Vet Res; 2018 Aug 22; 14(1):245. PubMed ID: 30134896
    [Abstract] [Full Text] [Related]

  • 20. Immune response against equine gammaherpesvirus in Icelandic horses.
    Svansson V, Roelse M, Olafsdóttir G, Thorsteinsdóttir L, Torfason EG, Torsteinsdóttir S.
    Vet Microbiol; 2009 Jun 12; 137(3-4):363-8. PubMed ID: 19217222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.